Conversely, overexpression of NONHSAG045500 led to a decrease in SERT in SK-N-SH neuroblastoma cells, which in turn compromised the efficacy of anti-multiple sclerosis medications and ultimately led to the failure of multiple sclerosis treatment [64]. The gene discussed is SLC6A4; the disease is neuroblastoma.